High quality cardiac toxicity data generation and interpretation is vital to the efficient progression of a drug discovery campaign. Metrion offers a range of translational, phenotypic cardiac assays and platforms that have been validated using a number of commercially available iPSC-derived cardiomyocyte cell lines.  Using technologies such as manual patch clamp electrophysiology, microelectrode array (MEA; Maestro platform) or dual MEA/impedance readouts (CardioExcyte96), Metrion can offer a direct readout of physiological function in the iPSC-derived cardiomyocyte cell line  of your choosing.